Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Activation of the niacin receptor HCA2 reduces demyelination and neurofilament loss, and promotes functional recovery after spinal cord injury in mice.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Cutaneous and Mixed Nerve Silent Period Recordings in Symptomatic Paroxysmal Kinesigenic Dyskinesia.
Identification of Ser-Pro-Cys-Peptide in Blood Serum of Multiple Sclerosis Patients.
Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
Autologous hematopoietic cell transplantation in multiple sclerosis.
Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia.
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.
Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?
Evaluation of transiently evoked otoacoustic emissions and auditory brainstem responses in patients with multiple sclerosis.
Neuroprotective effects of placenta-derived mesenchymal stromal cells in a rat model of experimental autoimmune encephalomyelitis.
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.
Evaluation of the benefits of treatment with TENS for neurological lower urinary tract dysfunctions.
Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis.
Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.
Retinal measures correlate with cognitive and physical disability in early multiple sclerosis.
[Therapy of fatigue in multiple sclerosis : A treatment algorithm].
Progressive Multifocal Leucoencephalopathy and psoriasis.
Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.
Impaired Frontolimbic Connectivity and Depressive Symptoms in Patients with Alzheimer's Disease.
Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
Recurrent myelopathy and optic neuritis associated with systemic lupus erythematosus.
Pages
« first
‹ previous
…
800
801
802
803
804
805
806
807
808
…
next ›
last »